These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31728384)

  • 1. Lower T cell inhibitory receptor level in mononuclear cells from cord blood compared with peripheral blood.
    Lin Y; Lin J; Huang J; Chen Y; Tan J; Li Y; Chen S
    Stem Cell Investig; 2019; 6():35. PubMed ID: 31728384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes.
    Kamal AM; Wasfey EF; Elghamry WR; Sabry OM; Elghobary HA; Radwan SM
    Clin Biochem; 2021 Oct; 96():13-18. PubMed ID: 34217699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different aberrant expression pattern of immune checkpoint receptors in patients with PTCL and NK/T-CL.
    Liao Z; Lv X; Liu S; He Z; Chen S; Wang L; Li W; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e252-e258. PubMed ID: 29368793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of PD-1, TIM-3, LAG-3 and BTLA in diffuse large B-cell lymphoma and its effect on prognosis].
    Liu XY; Yuan XL; Ma RJ; Xu H; Yang SW; Nie L; Zhang L; Hu AX; Li Z; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2846-2853. PubMed ID: 32988145
    [No Abstract]   [Full Text] [Related]  

  • 5. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
    Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood.
    Li Y; Chen S; Yang L; Li B; Chan JY; Cai D
    Transpl Immunol; 2009 Jan; 20(3):155-62. PubMed ID: 19013241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56
    Shereck E; Day NS; Awasthi A; Ayello J; Chu Y; McGuinn C; van de Ven C; Lim MS; Cairo MS
    Innate Immun; 2019 Jul; 25(5):294-304. PubMed ID: 31068047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
    Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS
    Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules.
    D'Arrigo P; Tufano M; Rea A; Vigorito V; Novizio N; Russo S; Romano MF; Romano S
    Curr Med Chem; 2020; 27(15):2402-2448. PubMed ID: 30398102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTLA: a new inhibitory receptor with a B7-like ligand.
    Carreno BM; Collins M
    Trends Immunol; 2003 Oct; 24(10):524-7. PubMed ID: 14552835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood-derived T cells allow the generation of a more naïve tumor-reactive cytotoxic T-cell phenotype.
    Kwoczek J; Riese SB; Tischer S; Bak S; Lahrberg J; Oelke M; Maul H; Blasczyk R; Sauer M; Eiz-Vesper B
    Transfusion; 2018 Jan; 58(1):88-99. PubMed ID: 29023759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis.
    Derniame S; Lee F; Domogala A; Madrigal A; Saudemont A
    Transplantation; 2014 Apr; 97(8):870-8. PubMed ID: 24670298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.
    Sawaf M; Fauny JD; Felten R; Sagez F; Gottenberg JE; Dumortier H; Monneaux F
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
    Tao R; Wang L; Han R; Wang T; Ye Q; Honjo T; Murphy TL; Murphy KM; Hancock WW
    J Immunol; 2005 Nov; 175(9):5774-82. PubMed ID: 16237069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma.
    Imai Y; Hasegawa K; Matsushita H; Fujieda N; Sato S; Miyagi E; Kakimi K; Fujiwara K
    Oncol Lett; 2018 May; 15(5):6457-6468. PubMed ID: 29616115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells.
    Li Y; Chen S; Yang L; Yin Q; Geng S; Wu X; Schmidt CA; Przybylski GK
    Transpl Immunol; 2007 Nov; 18(2):151-8. PubMed ID: 18005861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergism of B and T lymphocyte attenuator (BTLA) and cytotoxic T lymphocyte associated antigen-4 (CTLA-4) attenuated acute T-cell mediated rejection and prolonged renal graft survival.
    Zhang H; Wang Z; Zhang J; Zhang X; Gui Z; Sun L; Yang H; Tan R; Gu M
    Transl Androl Urol; 2020 Oct; 9(5):1990-1999. PubMed ID: 33209663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.